MOLECULAR DATA MKD

Market cap
$74.9M
P/E
0.0×

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 32.19%

Capital & Financial Ratios

Market Cap 74.92
Revenue 1,817.86
Net Income (78.07)
Free Cash Flow (65.72)
Net Debt (50.95)
Current Ratio 1.10
Debt/Equity 1.15
P/E ratio 0.00
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next 5Y EPS Growth —
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2021 Powerpack
2020 Powerpack
2019 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2018 2019 2020 Q'21
Cash 1 8 53 62
Receivables 9 12 9 11
Inventory 1 1 0 1
Other — — — —
54 70 102 113
2018 2019 2020 Q'21
Payables 7 44 48 49
ST’ Debt 0 2 8 9
Other — — — —
37 97 106 103
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — 23.24%
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 0.00%

Revenue

Mar Jun Sep Dec Year
’26 — 226 — — —
’20 — — — — 1,164
’19 — — 574 589 1,897
’18 — — 466 429 1,368
’17 — — — — 622
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 — (4) — — —
’20 — — — (36) (36)
’19 — — — (14) (14)
’18 — — — (12) (20)
’17 — — — — (27)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 — (4) — — —
’20 — — — (33) (33)
’19 — — — (14) (14)
’18 — — — (12) (20)
’17 — — — — (27)
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 — (0.03) — — —
’20 — — — — (5.85)
’19 — — (0.04) (0.45) (4.03)
’18 — — (0.04) (0.23) (0.37)
’17 — — — — (0.15)
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
— — — — — — — — — —

Analyst estimates 2021–2023

Powerpack
Low Price
— — — — — — — — — —
High Price
— — — — — — — 505 482 189
Employees
— — — — — 0 0 3 4 6
Revenue/Emp
— — — — — 483 622 1,368 1,897 1,164
Revenue
— — — — — 0.83% 1.13% 0.88% 0.76% (0.13%)
Gross Margin
— — — — — (17) (16) (38) (28) (50)
EBT
— — — — — (3.52%) (2.57%) (2.78%) (1.46%) (4.29%)
EBT Margin
— — — — — (17) 0 0 (28) (50)
Net Income
— — — — — 0 0 0 0 0
Depreciation
— — — — — 69.00 88.86 195.43 274.69 150.40
Revenue/Sh
— — — — — (0.06) (0.05) (0.12) (4.03) (6.30)
Earnings/Sh
— — — — — (3.22) (3.86) (2.91) (1.99) (4.63)
Cash Flow/Sh
— — — — — 0.00 0.00 0.00 (0.04) 0.33
Capex/Sh
— — — — — (3.22) (3.86) (2.91) (2.03) (4.30)
Free CF/Sh
— — — — — 0.00 0.13 (1.28) (4.50) (0.55)
Book Value/Sh
— — — — — 7 7 7 7 8
Shares
— — — — — 0.00 0.00 0.00 0.00 0.00
PE Ratio
— — — — — 0.00 0.00 0.00 0.05 0.01
PS Ratio
— — — — — 0.00 0.00 0.00 0.00 0.00
PB Ratio
— — — — — 0.00 0.00 0.00 0.05 (0.01)
EV/Sales
— — — — — 0.00 0.00 0.00 0.00 0.00
EV/FCF
— — — — — (23) (27) (20) (14) (36)
Op' Cash Flow
— — — — — 0 0 0 0 3
Capex
— — — — — (23) (27) (20) (14) (33)
FCF
— — — — — — 12 16 (27) (5)
Working Cap'
— — — — — — 33 26 6 11
Total Debt
— — — — — — 17 25 (2) (43)
Net Debt
— — — — — — 1 (9) (31) (4)
Sh' Equity
— — — — — 0.00% (28.41%) 0.00% (78.56%) (57.21%)
ROA
— — — — — — 0.00% 0.00% 0.00% 0.00%
ROIC
— — — — — 0.00% 396.55% 941.81% 138.75% 284.23%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2020 · latest quarter Jun 2021

MOLECULAR DATA peers in Chemicals

Company Market cap P/E Compare
ACNT Ascent Industries Co. $131.9M 0.0× Compare
BAK Braskem S.A. $272.2M 0.0× Compare
ASIX AdvanSix $425.3M 0.0× Compare
VHI Valhi, Inc. $454.6M 0.0× Compare
Company Market cap P/E Compare
ASPI ASP Isotopes Inc. $466.1M 0.0× Compare
RYAM Rayonier Advanced Materials Inc. $591.9M 0.0× Compare
TROX Tronox Holdings PLC $643.6M 0.0× Compare
LXU Lsb Industries Inc. $726.5M 19.8× Compare

All 17 Chemicals stocks →

MOLECULAR DATA (MKD) Latest News

News by impact score

Fine-tune

No news matches these filters.

stockrow.com/MKD · Data as of Jun 30, 2021 · For information only; not investment advice. · © 2026 stockrow.com